Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors

Tyrosine-kinase inhibitors (TKIs) demonstrate high inter-individual variability with respect to safety and efficacy and would therefore benefit from dose or schedule adjustments. This study investigated the efficacy, safety, and economical aspects of alternative dosing options for sunitinib in gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Centanni, Maddalena, Friberg, Lena E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080977/
https://www.ncbi.nlm.nih.gov/pubmed/32226388
http://dx.doi.org/10.3389/fphar.2020.00316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080977/
https://www.ncbi.nlm.nih.gov/pubmed/32226388
http://dx.doi.org/10.3389/fphar.2020.00316

Ejemplares similares